» Articles » PMID: 18627370

Hidradenitis Suppurativa: Are Tumour Necrosis Factor-alpha Blockers the Ultimate Alternative?

Overview
Journal Br J Dermatol
Specialty Dermatology
Date 2008 Jul 17
PMID 18627370
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Systematic review of immunomodulatory therapies for hidradenitis suppurativa.

Lim S, Oon H Biologics. 2019; 13:53-78.

PMID: 31190730 PMC: 6526329. DOI: 10.2147/BTT.S199862.


North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C J Am Acad Dermatol. 2019; 81(1):91-101.

PMID: 30872149 PMC: 9131892. DOI: 10.1016/j.jaad.2019.02.068.


Hidradenitis suppurativa: an update on connecting the tracts.

Smith M, Nicholson C, Parks-Miller A, Hamzavi I F1000Res. 2017; 6:1272.

PMID: 28794864 PMC: 5538037. DOI: 10.12688/f1000research.11337.1.


Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.

Scuderi N, Monfrecola A, Dessy L, Fabbrocini G, Megna M, Monfrecola G Skin Appendage Disord. 2017; 3(2):95-110.

PMID: 28560220 PMC: 5436059. DOI: 10.1159/000462979.


Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.

Napolitano M, Megna M, Timoshchuk E, Patruno C, Balato N, Fabbrocini G Clin Cosmet Investig Dermatol. 2017; 10:105-115.

PMID: 28458570 PMC: 5402905. DOI: 10.2147/CCID.S111019.